Managed Care
Specialty Pharmacy Economics Require Comprehensive Cost Management Beyond Drug Trend
Specialty drug costs continue rising, but traditional specialty drug trend metrics fail to capture the full economic picture for payers. A comprehensive view of specialty pharmacy economics includes rebates, dispensing fees, patient assistance programs, and site-of-care differentials that significantly affect net costs. Managed care organizations that analyze total cost of care rather than gross trend alone can identify opportunities to steer utilization to lower-cost sites and negotiate more favorable arrangements with specialty pharmacies and manufacturers. The analysis suggests payers should evaluate specialty pharmacy performance using net cost metrics that account for all payment flows, not just claims data.
Why it mattersSpecialty drugs represent the fastest-growing pharmacy cost category for Medicaid MCOs, and accurately measuring net costs after rebates and other offsets is essential for effective formulary management, network design, and rate negotiation with states.